Cargando…
Advances in Multiple Sclerosis Research–Series I
Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular, multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special I...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692630/ https://www.ncbi.nlm.nih.gov/pubmed/33137992 http://dx.doi.org/10.3390/brainsci10110795 |
_version_ | 1783614556829908992 |
---|---|
author | Apostolopoulos, Vasso Matsoukas, John |
author_facet | Apostolopoulos, Vasso Matsoukas, John |
author_sort | Apostolopoulos, Vasso |
collection | PubMed |
description | Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular, multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue, “Advances in Multiple Sclerosis Research—Series I”, focused on delivery methods used for immunotherapeutic approaches, drug design, anti-inflammatories, identification of markers, methods for detection and monitoring MS and treatment modalities. The issue gained much attention with 20 publications, and, as a result, we launched Series II with the deadline for submission being 30 April 2021. |
format | Online Article Text |
id | pubmed-7692630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76926302020-11-28 Advances in Multiple Sclerosis Research–Series I Apostolopoulos, Vasso Matsoukas, John Brain Sci Editorial Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular, multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue, “Advances in Multiple Sclerosis Research—Series I”, focused on delivery methods used for immunotherapeutic approaches, drug design, anti-inflammatories, identification of markers, methods for detection and monitoring MS and treatment modalities. The issue gained much attention with 20 publications, and, as a result, we launched Series II with the deadline for submission being 30 April 2021. MDPI 2020-10-29 /pmc/articles/PMC7692630/ /pubmed/33137992 http://dx.doi.org/10.3390/brainsci10110795 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Apostolopoulos, Vasso Matsoukas, John Advances in Multiple Sclerosis Research–Series I |
title | Advances in Multiple Sclerosis Research–Series I |
title_full | Advances in Multiple Sclerosis Research–Series I |
title_fullStr | Advances in Multiple Sclerosis Research–Series I |
title_full_unstemmed | Advances in Multiple Sclerosis Research–Series I |
title_short | Advances in Multiple Sclerosis Research–Series I |
title_sort | advances in multiple sclerosis research–series i |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692630/ https://www.ncbi.nlm.nih.gov/pubmed/33137992 http://dx.doi.org/10.3390/brainsci10110795 |
work_keys_str_mv | AT apostolopoulosvasso advancesinmultiplesclerosisresearchseriesi AT matsoukasjohn advancesinmultiplesclerosisresearchseriesi |